| Total (n = 500) | Normal TG (n = 202) | Borderline-high TG (n = 77) | High TG (n = 183) | Very high TG (n = 38) |
---|---|---|---|---|---|
Age(yr) | 56.7 ± 9.0 | 55.6 ± 9.7 | 55.8 ± 8.7 | 57.3 ± 9.2 | 58.6 ± 9.0 |
Female/male | 175/325 | 72/130 | 26/51 | 64/119 | 13/25 |
Sex ratio(%) | 53.8 | 55.4 | 50.9 | 53.8 | 52.0 |
BMI(kg/m 2 ) | 23.4 ± 2.2 | 22.4 ± 2.5 | 23.4 ± 2.8 | 24.5 ± 2.8a§ | 26.2 ± 3.0a§ b§ |
TG(mmol/L) | 2.1 ± 0.3 | 1.0 ± 0.2 | 1.9 ± 0.2 a§ | 3.3 ± 0.8a§ b§ | 7.1 ± 1.0a§ b§ c§ |
TC(mmol/L) | 5.4 ± 0.9 | 5.0 ± 0.8 | 5.2 ± 0.9 | 5.5 ± 0.9a‡ | 6.1 ± 0.8a§ b§ c‡ |
LDL-C(mmol/L) | 3.3 ± 0.4 | 2.8 ± 0.7 | 3.0 ± 0.8 | 3.4 ± 0.8a‡b* | 3.5 ± 0.9a‡b‡ |
HDL-C(mmol/L) | 1.2 ± 0.3 | 1.6 ± 0.3 | 1.3 ± 0.4a§ | 1.0 ± 0.4a§b§ | 0.9 ± 0.2a§b§ |
ApoA-I(mg/L) | 1270.2 ± 102.5 | 1319.1 ± 193.8 | 1300.0 ± 178.4 | 1257.2 ± 151.2 | 1187.9 ± 123.2a‡ b‡ c* |
ApoB-100(mg/L) | 905.6 ± 98.4 | 804.3 ± 97.7 | 905.6 ± 108.4a‡ | 1015.4 ± 119.1a§ b‡ | 1167.2 ± 113.9a§ b§ c‡ |
ApoC-II(mg/L) | 62.5 ± 10.8 | 45.4 ± 9.5 | 66.7 ± 11.9a* | 101.9 ± 17.3a§ b‡ | 140.2 ± 25.3a§ b§ c‡ |
ApoC-III(mg/L) | 150.2 ± 25.6 | 112.9 ± 21.9 | 152.3 ± 23.2a§ | 196.8 ± 27.5a§ b§ | 252.4 ± 29.8a§ b§ c§ |
TG/HDL-C | 2.1 ± 0.2 | 0.8 ± 0.2 | 1.3 ± 0.3a§ | 3.5 ± 0.9a§b§ | 5.4 ± 0.9a§ b§c§ |
TC/HDL-C | 4.8 ± 0.3 | 4.0 ± 1.0 | 4.7 ± 1.0a* | 5.7 ± 1.0a§b‡ | 6.1 ± 1.1a§ b§ |
LDL-C/HDL-C | 2.8 ± 0.2 | 1.3 ± 0.2 | 1.8 ± 0.3a‡ | 2.6 ± 0.5a§b‡ | 3.0 ± 0.9a§ b§c* |
ApoB-100/A-I | 0.7 ± 0.2 | 0.4 ± 0.1 | 0.5 ± 0.2 | 0.8 ± 0.2a§b‡ | 1.1 ± 0.3a§ b§c‡ |
ApoC-III/C-II | 2.4 ± 0.3 | 2.5 ± 0.3 | 2.3 ± 0.2 | 1.9 ± 0.2a§b‡ | 1.8 ± 0.2a§b‡ |